Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

Adam M Staffaroni | Lynn Bajorek | Kaitlin B Casaletto | Yann Cobigo | Sheng-Yang M Goh | Amy Wolf | Hilary W Heuer | Fanny M Elahi | Peter A Ljubenkov | Reilly Dever | John Kornak | Brian Appleby | Jessica Bove | Yvette Bordelon | Patrick Brannelly | Danielle Brushaber | Christina Caso | Giovanni Coppola | Christina Dheel | Bradford C Dickerson | Susan Dickinson | Sophia Dominguez | Kimiko Domoto-Reilly | Kelly Faber | Jessica Ferrall | Julie A Fields | Ann Fishman | Jamie Fong | Tatiana Foroud | Leah K Forsberg | Ralitza Gavrilova | Debra Gearhart | Behnaz Ghazanfari | Nupur Ghoshal | Jill Goldman | Jonathan Graff-Radford | Neill Graff-Radford | Ian Grant | Murray Grossman | Dana Haley | Ging-Yuek Hsiung | Edward D Huey | David J Irwin | David T Jones | Lynne Jones | Kejal Kantarci | Anna Karydas | Daniel I Kaufer | Diana R Kerwin | David S Knopman | Ruth Kraft | Walter K Kremers | Walter A Kukull | Irene Litvan | Diane Lucente | Codrin Lungu | Ian R Mackenzie | Miranda Maldonado | Masood Manoochehri | Scott M McGinnis | Emily McKinley | Mario F Mendez | Bruce L Miller | Namita Multani | Chiadi Onyike | Jaya Padmanabhan | Alex Pantelyat | Rodney Pearlman | Len Petrucelli | Madeline Potter | Rosa Rademakers | Eliana Marisa Ramos | Katherine P Rankin | Katya Rascovsky | Erik D Roberson | Emily Rogalski | Pheth Sengdy | Leslie M Shaw | Jeremy Syrjanen | M Carmela Tartaglia | Nadine Tatton | Joanne Taylor | Arthur Toga | John Q Trojanowski | Sandra Weintraub | Ping Wang | Bonnie Wong | Zbigniew Wszolek | Adam L Boxer | Brad F Boeve | Joel H Kramer | Howard J Rosen | ARTFL/LEFFTDS consortium
Alzheimer's & dementia : the journal of the Alzheimer's Association | 2020

Identifying clinical measures that track disease in the earliest stages of frontotemporal lobar degeneration (FTLD) is important for clinical trials. Familial FTLD provides a unique paradigm to study early FTLD. Executive dysfunction is a clinically relevant hallmark of FTLD and may be a marker of disease progression.

Pubmed ID: 31914230 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Biogen, International
  • Agency: NIA NIH HHS, United States
    Id: K24 AG045333
  • Agency: NIA NIH HHS, United States
    Id: U24 AG021886
  • Agency: NIA NIH HHS, United States
    Id: P01 AG017586
  • Agency: Genentech, International
  • Agency: NIA NIH HHS, United States
    Id: P01 AG019724
  • Agency: NIA NIH HHS, United States
    Id: P01 AG066597
  • Agency: Association for Frontotemporal Degeneration, International
  • Agency: CIHR, Canada
  • Agency: NIA NIH HHS, United States
    Id: R01 AG062268
  • Agency: NIA NIH HHS, United States
    Id: U01 AG045390
  • Agency: Roche, International
  • Agency: University of Southern California, International
  • Agency: NIA NIH HHS, United States
    Id: P30 AG013854
  • Agency: Larry L. Hillblom Foundation, International
  • Agency: Allergan, International
  • Agency: NIA NIH HHS, United States
    Id: K23 AG061253
  • Agency: Bristol-Myers Squibb, International
  • Agency: DOD, International
  • Agency: Eisai, International
  • Agency: AbbVie, International
  • Agency: Janssen Pharmaceuticals, International
  • Agency: NIA NIH HHS, United States
    Id: P30 AG062421
  • Agency: Pfizer, International
  • Agency: NIA NIH HHS, United States
    Id: P50 AG008702
  • Agency: NIA NIH HHS, United States
    Id: U19 AG063911
  • Agency: Alzheimer's Association, United States
  • Agency: NIA NIH HHS, United States
    Id: U01 AG016976
  • Agency: NIH HHS, United States
    Id: AG045390
  • Agency: BrightFocus Foundation, International
  • Agency: Merck, International
  • Agency: GE Healthcare, International
  • Agency: NIA NIH HHS, United States
    Id: P50 AG005136
  • Agency: Wyeth, International
  • Agency: NIA NIH HHS, United States
    Id: T32 AG023481
  • Agency: Parkinson Foundation, International
  • Agency: NIA NIH HHS, United States
    Id: R01 AG032306
  • Agency: Michael J. Fox Foundation, International
  • Agency: Alzheimer's Drug Discovery Foundation, International
  • Agency: New York State Department of Health, International
    Id: 1510130358
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH120794
  • Agency: Alzheimer Society of British Columbia, International
  • Agency: Tau Consortium and Association for Frontotemporal Dementia, International
  • Agency: NIA NIH HHS, United States
    Id: P30 AG066509
  • Agency: HDSA, International
  • Agency: NINDS NIH HHS, United States
    Id: U54 NS092089
  • Agency: Eli Lilly, International
  • Agency: NINDS, International
  • Agency: Avid, and Piramal, International
  • Agency: CDC, International
  • Agency: AstraZeneca, International
  • Agency: Penn Institute on Aging, International

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Ramos (tool)

RRID:CVCL_0597

Cell line Ramos is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions